A multicenter comparative matched-pair analysis of percutaneous tumor ablation and robotic-assisted partial nephrectomy of T1b renal cell carcinoma (AblatT1b study-UroCCR 80).

Date publication

avril 2023

Journal

European radiology

Auteurs

Membres identifiés du Cancéropôle Est :
Pr GANGI Afshin

Tous les auteurs :
Cazalas G, Klein C, Piana G, De Kerviler E, Gangi A, Puech P, Nedelcu C, Grange R, Buy X, Jegonday MA, Bigot P, Bensalah CK, Gaillard V, Pignot G, Paparel P, Badet L, Michiels C, Bernhard JC, Rouviere O, Grenier N, Marcelin C

Lien Pubmed

https://www.ncbi.nlm.nih.gov/pubmed/37004570

Résumé

Renal cell carcinomas represent the sixth- and tenth-most frequently diagnosed cancer in men and women. Recently, percutaneous-guided thermal ablations have proved to be as effective as partial nephrectomy and safer for treating small renal masses (i.e.,  < 3 cm). This study compared the perioperative and recurrence outcomes of percutaneous thermal ablation (TA) and robotic-assisted partial nephrectomy (RAPN) for the treatment of T1b renal cell carcinomas (4.1-7 cm).

Mots clés

Ablation, Kidney neoplasm, Neoplasm recurrence, local, Radiology, interventional, Surgery

Référence

Eur Radiol. 2023 04 1;: